US Stock MarketDetailed Quotes
BFRI Biofrontera
- 0.8700
- +0.1110+14.62%
Close Nov 22 16:00 ET
- 0.9435
- +0.0735+8.45%
Pre 04:32 ET
6.74MMarket Cap0.75P/E (TTM)
0.9300High0.7777Low9.50MVolume0.7950Open0.7590Pre Close10.84MTurnover181.36%Turnover RatioLossP/E (Static)7.75MShares4.040052wk High1.22P/B4.56MFloat Cap0.610052wk Low--Dividend TTM5.24MShs Float292.6000Historical High--Div YieldTTM20.07%Amplitude0.6100Historical Low1.1400Avg Price1Lot Size
Biofrontera Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 39.72%-1.21M | 54.33%-4.72M | 9.87%-3.33M | -53.68%-24.9M | -7.19%-8.87M | 66.27%-2M | -8,368.80%-10.34M | -74.67%-3.69M | 39.36%-16.2M | 60.60%-8.27M |
| Net income from continuing operations | 10.61%-5.67M | 97.39%-257K | -39.57%-10.44M | -3,045.47%-20.13M | 226.61%3.53M | -147.16%-6.34M | -1,057.29%-9.84M | -234.47%-7.48M | 98.30%-640K | 80.80%-2.79M |
| Operating gains losses | -57.78%681K | -589.53%-5.42M | 95.61%3.74M | 80.85%-3.14M | -593.40%-7.77M | 236.12%1.61M | 120.63%1.11M | 121.96%1.91M | -228.02%-16.39M | ---1.12M |
| Depreciation and amortization | 24.30%312K | 22.62%309K | 15.41%307K | -9.22%1.06M | -62.08%295K | 91.60%251K | 90.91%252K | 103.05%266K | 117.04%1.17M | 493.89%778K |
| Other non cash items | -99.35%2K | -52.74%95K | 236.04%151K | -99.97%-6.88M | -1,966.41%-7.28M | 114.50%306K | 111.10%201K | -224.72%-111K | -229.69%-3.44M | 112.96%390K |
| Change In working capital | 68.40%3.14M | 114.44%342K | 93.07%2.62M | -257.60%-4.39M | -26.03%-5.25M | 416.98%1.87M | -132.53%-2.37M | 423.55%1.36M | 285.25%2.79M | 74.83%-4.16M |
| -Change in receivables | -215.45%-1.39M | -88.83%173K | -39.68%1.41M | 0.28%4.93M | 163.61%1.49M | -11,100.00%-440K | -82.24%1.55M | 259.33%2.34M | 141.00%4.92M | 82.32%-2.34M |
| -Change in inventory | -101.17%-2.58M | 136.45%2.96M | 702.20%4M | -33.45%-3.75M | 4.72%5.15M | 60.87%-1.28M | -101.14%-8.12M | 220.53%499K | -208.41%-2.81M | 402.35%4.92M |
| -Change in prepaid assets | -90.45%62K | -82.77%91K | 85.66%-119K | -95.81%174K | -624.24%-173K | 53.43%649K | 528.57%528K | -122.97%-830K | 209.06%4.15M | 100.82%33K |
| -Change in payables and accrued expense | -32.41%2.07M | -171.54%-2.71M | -384.75%-2.51M | 102.37%64K | -4.53%-6.27M | 35.26%3.06M | 50.86%3.79M | 64.83%-518K | -123.01%-2.7M | -2,097.07%-6M |
| -Change in other current assets | ---- | ---- | ---- | ---5.16M | ---5.16M | ---- | ---- | ---- | --0 | ---- |
| -Change in other current liabilities | -47.50%-177K | -38.84%-168K | -23.88%-166K | 15.88%-657K | ---282K | ---120K | ---121K | ---134K | ---781K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 39.72%-1.21M | 54.33%-4.72M | 9.87%-3.33M | -53.68%-24.9M | -7.19%-8.87M | 66.27%-2M | -8,368.80%-10.34M | -74.67%-3.69M | 39.36%-16.2M | 60.60%-8.27M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | -101.12%-2K | 0 | 112.01%619K | 103.50%73K | 112.59%382K | 674.19%178K | -180.00%-14K | -46,772.73%-5.16M | -23,077.78%-2.09M |
| Net PPE purchase and sale | --0 | --48K | -307.14%-57K | 86.84%-5K | 1,000.00%9K | --0 | --0 | -180.00%-14K | -245.45%-38K | 88.89%-1K |
| Net intangibles purchase and sale | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net investment purchase and sale | --0 | --0 | --57K | 112.19%624K | 101.25%64K | --382K | --178K | --0 | ---5.12M | ---5.12M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | -101.12%-2K | --0 | 112.01%619K | 103.50%73K | 112.59%382K | 674.19%178K | -180.00%-14K | -46,772.73%-5.16M | -23,077.78%-2.09M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -150.42%-298K | 377.76%5.28M | 5.8M | -40.01%8.41M | 6.71M | -87.24%591K | 1.11M | 0 | -67.54%14.02M | 0 |
| Net issuance payments of debt | -210.83%-655K | -294.76%-2.15M | ---1.51M | --3.9M | --2.21M | --591K | --1.11M | --0 | --0 | --0 |
| Net common stock issuance | ---- | ---- | ---- | -52.01%4.51M | ---- | ---- | ---- | ---- | -68.63%9.39M | --0 |
| Net preferred stock issuance | --0 | --0 | --7.66M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -65.06%4.63M | --0 |
| Net other financing activities | ---- | --0 | ---357K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -150.42%-298K | 377.76%5.28M | --5.8M | -40.01%8.41M | --6.71M | -87.24%591K | --1.11M | --0 | -67.54%14.02M | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -1.59%4.58M | -70.69%4.02M | -91.14%1.54M | -29.64%17.41M | -86.95%3.62M | -85.51%4.65M | -39.43%13.71M | -29.64%17.41M | 198.92%24.74M | 1,351.39%27.77M |
| Current changes in cash | -46.07%-1.51M | 106.21%562K | 166.81%2.47M | -116.32%-15.87M | 79.93%-2.08M | 76.27%-1.03M | -195.43%-9.05M | -74.92%-3.7M | -144.54%-7.33M | -145.37%-10.36M |
| End cash Position | -15.16%3.07M | -1.59%4.58M | -70.69%4.02M | -91.14%1.54M | -91.14%1.54M | -86.95%3.62M | -85.51%4.65M | -39.43%13.71M | -29.64%17.41M | -29.64%17.41M |
| Free cash flow | 39.72%-1.21M | 54.32%-4.72M | 8.67%-3.38M | -53.35%-24.9M | -7.07%-8.86M | 66.27%-2M | -11,095.74%-10.34M | -74.92%-3.7M | 39.25%-16.24M | 60.61%-8.27M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
